Why the study?
Does prolonged tailored immunosuppressive therapy improve efficacy and safety in patients with immune-mediated biopsy-proven myocarditis?
Does prolonged tailored immunosuppressive therapy improve efficacy and safety in patients with immune-mediated biopsy-proven myocarditis?
Prolonged tailored immunosuppressive therapy is effective and safe for immune-mediated biopsy-proven myocarditis.
Answers are grounded in this paper and cite their sources.
May support tailored immunosuppression in biopsy-proven myocarditis; hypothesis-generating and requires randomized confirmation.
Prolonged tailored IS is effective and safe in BP immune-mediated myocarditis irrespective of histology and clinical presentation.
No takes yet. Share an insight, caveat, or question.
Caforio et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: